Forest Laboratories names Icahn designee to board
Forest Laboratories seated a new board member selected by Carl Icahn, averting a fight over control of the pharmaceutical company. Full story
Wall St. ends higher in late rebound
NEW YORK (Reuters) - Stocks rose on Monday as weaker-than-expected factory activity last month supported views that the Federal Reserve will need to keep economic stimulus in place, while gains in Merck & Co's <MRK.N> lifted drug companies. Full story
Faber Report: Valeant Agrees to Buy Bausch & Lomb
CNBC's David Faber reports the Canadian pharmaceutical company is buying eye-care company Bausch & Lomb for $8.7 billion from Warburg Pincus.
Sponsored Links
Video
'Pay For Delay' Case
The Supreme Court is taking on the "pay for delay" method used by big pharmaceutical companies, and pilots at American Airlines voted to ratify a new contract, reports CNBC's Brian Shactman.
advertisement | ad info
Related Photos
The new logo of bio pharmaceutical company Merck Serono SA is pictured outside the new headquarters in Geneva
The new logo of bio pharmaceutical company Merck Serono SA is pictured outside the new headquarters in Geneva January 8, 2007. REUTERS/Denis Balibouse
The logo of Swiss pharmaceutical company Roche is seen at the company's headquarters in Basel
The logo of Swiss pharmaceutical company Roche is seen at the company's headquarters in Basel April 5, 2012. REUTERS/Arnd Wiegmann
Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz
A logo of Swiss pharmaceutical company Roche is pictured in front of a company's building in Rotkreuz, April 12, 2012. REUTERS/Michael Buholzer
